Paul B. Watkins, M.D.
|
Director, the DILI-sim Initiative | Chairman, DILI-sim Scientific Advisory Board | Director, UNC Institute for Drug Safety Sciences |
David S. Pisetsky, M.D., Ph.D.
|
Professor of Medicine (Rheumatology and Immunology) Duke University |
Kevin Park, Ph.D., FMedSci, FRCP (Hon), FTBS
|
Professor of Molecular and Clinical Pharmacology, Director of MRC Centre for Drug Safety Science, and Head of the Institute of Translational Medicine University of Liverpool |
Neil Kaplowitz, M.D.
|
Professor of Medicine Chief Division of Gastrointestinal and Liver Disease University of Southern California Liver Transplant Program and Center for Liver Disease University of Southern California |
Robert A. Roth, Ph.D., DABT
|
Distinguished Professor, Professor of Pharmacology & Toxicology Director, Graduate Training Program in Environmental and Integrative Toxicological Sciences, Center for Integrative Toxicology, Michigan State University |
Jack Uetrecht, M.D., Ph.D.
|
Professor of Pharmacy and Medicine and Canada Research Chair in Adverse Drug Reactions, University of Toronto |